Literature DB >> 12669309

Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1.

Osamu Hashimoto1, Takato Ueno, Rina Kimura, Motoaki Ohtsubo, Toru Nakamura, Hironori Koga, Takuji Torimura, Sanae Uchida, Katsumi Yamashita, Michio Sata.   

Abstract

Transforming growth factor beta1 (TGF beta 1)-induced G2 arrest was observed when a proliferation inhibitory function of the retinoblastoma protein (Rb) was compromised, but the mechanism underlying the G2 arrest was poorly characterized compared with that of G1 arrest. In the present study, we characterized G2 arrest induced by TGF beta1 (1 ng/mL) in the Rb-negative hepatoma cell line (Hep3B) and compared with G1 arrest in the Rb-positive hepatoma cell line (Huh7). Activities of cyclin-dependent kinases (CDK) 2 and cell division cycle (CDC) 2 were markedly decreased at 24 h, the time when cell-cycle arrest became apparent in both cell lines. However, considerable amounts of inactive CDC2-cyclinB1 complexes were present in the nucleus of G2-arrested Hep3B but were not present in G1-arrested Huh7. The inhibitory phosphorylation of CDC2 on Tyr-15 was significantly elevated at 12-24 h, and its levels gradually declined during G2 arrest in Hep3B. In particular, augmentation of CDK inhibitors p21cip1 and p27kip1 and Wee1 kinase and diminution of CDC25C phosphatase coincided with induced Tyr-15 phosphorylation and inhibition of CDC2. Wee1 in Hep3B was unstable and was degraded in a proteasome-dependent manner, but it became substantially stabilized within 6 h of TGF beta 1 treatment. Moreover, a Wee1 inhibitor, PD0166285, abrogated the TGF beta 1-induced G2 arrest in Hep3B. These findings suggest that TGF beta 1 induced G2 arrest in Hep3B at least in part through stabilization of Wee1 and subsequent increase in Tyr-15 phosphorylation and inhibition of CDC2. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669309     DOI: 10.1002/mc.10111

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  11 in total

Review 1.  Biologic impact of proteasome inhibition in multiple myeloma cells--from the aspects of preclinical studies.

Authors:  Teru Hideshima; Kenneth C Anderson
Journal:  Semin Hematol       Date:  2012-07       Impact factor: 3.851

2.  Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803.

Authors:  Xia Liu; Jingze Wang; Bo Sun; Yajing Zhang; Jin Zhu; Changling Li
Journal:  Invest New Drugs       Date:  2007-07-10       Impact factor: 3.850

3.  Transforming growth factor-β decreases side population cells in hepatocellular carcinoma in vitro.

Authors:  Jong Bin Kim; Seulki Lee; Hye Ri Kim; Seo-Young Park; Minjong Lee; Jung-Hwan Yoon; Yoon Jun Kim
Journal:  Oncol Lett       Date:  2018-04-05       Impact factor: 2.967

4.  Deubiquitinase-targeting chimeras for targeted protein stabilization.

Authors:  Nathaniel J Henning; Lydia Boike; Jessica N Spradlin; Carl C Ward; Gang Liu; Erika Zhang; Bridget P Belcher; Scott M Brittain; Matthew J Hesse; Dustin Dovala; Lynn M McGregor; Rachel Valdez Misiolek; Lindsey W Plasschaert; David J Rowlands; Feng Wang; Andreas O Frank; Daniel Fuller; Abigail R Estes; Katelyn L Randal; Anoohya Panidapu; Jeffrey M McKenna; John A Tallarico; Markus Schirle; Daniel K Nomura
Journal:  Nat Chem Biol       Date:  2022-02-24       Impact factor: 16.174

5.  Fine tuning the cell cycle: activation of the Cdk1 inhibitory phosphorylation pathway during mitotic exit.

Authors:  Tamara A Potapova; John R Daum; Kendra S Byrd; Gary J Gorbsky
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

6.  Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.

Authors:  Osamu Hashimoto; Masako Shinkawa; Takuji Torimura; Toru Nakamura; Karuppaiyah Selvendiran; Masaharu Sakamoto; Hironori Koga; Takato Ueno; Michio Sata
Journal:  BMC Cancer       Date:  2006-12-19       Impact factor: 4.430

7.  Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.

Authors:  Qingxi Yue; Hong Zhen; Ming Huang; Xi Zheng; Lixing Feng; Baohong Jiang; Min Yang; Wanying Wu; Xuan Liu; Dean Guo
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

8.  Overexpression of USF increases TGF-beta1 protein levels, but G1 phase arrest was not induced in FRTL-5 cells.

Authors:  Keun-Sook Kim; Hye Seung Jung; Yun Jae Chung; Tae Sik Jung; Hye Won Jang; Myung-Shik Lee; Kwang-Won Kim; Jae Hoon Chung
Journal:  J Korean Med Sci       Date:  2008-10       Impact factor: 2.153

9.  A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.

Authors:  Andres Rojas; Pingyu Zhang; Ying Wang; Wai Chin Foo; Nina M Muñoz; Lianchun Xiao; Jing Wang; Gregory J Gores; Mien-Chie Hung; Boris Blechacz
Journal:  Neoplasia       Date:  2016-06       Impact factor: 5.715

10.  Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses.

Authors:  Peng-Chan Lin; Yi-Fang Yang; Yu-Chang Tyan; Eric S L Hsiao; Po-Chen Chu; Chung-Ta Lee; Jenq-Chang Lee; Yi-Ming Arthur Chen; Pao-Chi Liao
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.